PATENT CLAIM ANALYSIS

Application Number: 15760374
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "063000"]

Abstract:
To obtain a novel therapeutic drug for a malignant tumor or fibrosis. Used is a compound represented by formula (1), a salt thereof, or a solvate thereof. Also used is a therapeutic drug for a malignant tumor or a therapeutic drug for fibrosis, comprising a compound represented by formula (1), a salt thereof, or a solvate thereof.

Claim (Index 1):
A compound, a salt thereof, or a solvate thereof, the compound represented by formula (1): wherein substituents R 1  and R 2  are represented by the following case (a) or (b):\n (a) R 1  is optionally substituted phenyl, and\n R 2  is H, optionally substituted phenyl, or \u2014C(O)NHR 3  where the R 3  is H, C 1-6  alkyl, or optionally substituted benzyl; or \n \n (b) R 1  is optionally substituted naphthyl or optionally substituted phenyl, and\n R 2  is optionally substituted phenyl or \u2014C(O)NHR 4  where the R 4  is H, C 1-6  alkyl, or optionally substituted siloxybenzyl.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 2.46429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14871472', '14111757', '14092425', '15475108', '15434531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7869824436008241
- 35 USC 102 Novelty (BERT): 0.4967760217345019
- Combined Prediction Score: 0.7579618014141919
- Mean Citation Score: 264.80514000000005
- Max Citation Score: 266.23618
- Similarity Product: 223.9875955157316

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test